Literature DB >> 26437893

Preoperative neutrophil to lymphocyte ratio predicts survival in patients with T1-2N0 colorectal cancer.

Jun Sang Shin1, Kwang Wook Suh1, Seung Yeop Oh1.   

Abstract

PURPOSE: Neutrophil to lymphocyte ratio (NLR) is reported to be associated with prognosis of colorectal cancer. The aim of this study is to determine whether the NLR is a predictor of oncological outcomes in patients with stage I colorectal cancer who underwent curative surgery.
METHODS: Two hundred sixty-nine patients with stage I colorectal cancer who underwent surgical resection between December 2003 and December 2011 were retrospectively reviewed. The cutoff for NLR was defined as three by maximizing log-rank test statistics. We compared patients with a low NLR and those with a high NLR in terms of survival.
RESULTS: The 5-year disease-free survival (DFS) and cancer-specific survival (CSS) rates were lower in patients with a high NLR compared to those with a low NLR in stage I colorectal cancer (89.5% vs. 97.4%, P = 0.006; 94.0% vs. 98.9%, P = 0.022). Cox multivariate analysis demonstrated that preoperative NLR was independently associated with DFS (HR, 5.216; 95%CI, 1.400-19.431; P = 0.014) and CSS (HR, 6.190; 95%CI, 1.034-37.047; P = 0.046) in patients with stage I colorectal cancer.
CONCLUSION: The preoperative NLR is a prognostic factor predicting DFS and CSS in patients with stage I colorectal cancer who underwent curative surgery.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  colorectal cancer; lymphocyte; neutrophil; prognosis

Mesh:

Year:  2015        PMID: 26437893     DOI: 10.1002/jso.24061

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  14 in total

1.  Prognostic Significance of Lymphocyte Counts in Colon Cancer Patients Treated with FOLFOX Chemotherapy.

Authors:  O Kyu Noh; Seung Yeop Oh; Young Bae Kim; Kwang Wook Suh
Journal:  World J Surg       Date:  2017-11       Impact factor: 3.352

2.  Prognostic Impact of the Neutrophil-to-Lymphocyte Ratio in Borderline Resectable Pancreatic Ductal Adenocarcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgical Resection.

Authors:  Hirokazu Kubo; Takashi Murakami; Ryusei Matsuyama; Yasuhiro Yabushita; Nobuhiro Tsuchiya; Yu Sawada; Yuki Homma; Takafumi Kumamoto; Itaru Endo
Journal:  World J Surg       Date:  2019-12       Impact factor: 3.352

3.  Elevated NLR in gallbladder cancer and cholangiocarcinoma - making bad cancers even worse: results from the US Extrahepatic Biliary Malignancy Consortium.

Authors:  Eliza W Beal; Lai Wei; Cecilia G Ethun; Sylvester M Black; Mary Dillhoff; Ahmed Salem; Sharon M Weber; Thuy Tran; George Poultsides; Andre Y Son; Ioannis Hatzaras; Linda Jin; Ryan C Fields; Stefan Buettner; Timothy M Pawlik; Charles Scoggins; Robert C G Martin; Chelsea A Isom; Kamron Idrees; Harveshp D Mogal; Perry Shen; Shishir K Maithel; Carl R Schmidt
Journal:  HPB (Oxford)       Date:  2016-09-24       Impact factor: 3.647

4.  Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict chemotherapy outcomes and prognosis in patients with colorectal cancer and synchronous liver metastasis.

Authors:  Yuchen Wu; Cong Li; Jiang Zhao; Li Yang; Fangqi Liu; Hongtu Zheng; Zhimin Wang; Ye Xu
Journal:  World J Surg Oncol       Date:  2016-11-16       Impact factor: 2.754

5.  Prognostic efficacy of inflammation-based markers in patients with curative colorectal cancer resection.

Authors:  Özgür Akgül; Erdinç Çetinkaya; Metin Yalaza; Sabri Özden; Mesut Tez
Journal:  World J Gastrointest Oncol       Date:  2017-07-15

Review 6.  Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysis.

Authors:  Randy C Bowen; Nancy Ann B Little; Joshua R Harmer; Junjie Ma; Luke G Mirabelli; Kyle D Roller; Andrew Mackay Breivik; Emily Signor; Alec B Miller; Hung T Khong
Journal:  Oncotarget       Date:  2017-05-09

7.  Combined Detection of Preoperative Neutrophil-to-Lymphocyte Ratio and CEA as an Independent Prognostic Factor in Nonmetastatic Patients Undergoing Colorectal Cancer Resection Is Superior to NLR or CEA Alone.

Authors:  Xiaoli Zhan; Xiaobo Sun; Yonggang Hong; Yuedong Wang; Kefeng Ding
Journal:  Biomed Res Int       Date:  2017-06-08       Impact factor: 3.411

8.  Pre-treatment inflammatory indexes as predictors of survival and cetuximab efficacy in metastatic colorectal cancer patients with wild-type RAS.

Authors:  Jing Yang; Xinli Guo; Manni Wang; Xuelei Ma; Xiaoyang Ye; Panpan Lin
Journal:  Sci Rep       Date:  2017-12-07       Impact factor: 4.379

9.  The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: Systematic review and meta-analysis.

Authors:  Ross D Dolan; Jason Lim; Stephen T McSorley; Paul G Horgan; Donald C McMillan
Journal:  Sci Rep       Date:  2017-12-01       Impact factor: 4.379

10.  Prognostic significance of the combination of preoperative hemoglobin and albumin levels and lymphocyte and platelet counts (HALP) in patients with renal cell carcinoma after nephrectomy.

Authors:  Ding Peng; Cui-Jian Zhang; Qi Tang; Lei Zhang; Kai-Wei Yang; Xiao-Teng Yu; Yanqing Gong; Xue-Song Li; Zhi-Song He; Li-Qun Zhou
Journal:  BMC Urol       Date:  2018-03-15       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.